-
1دورية أكاديمية
المؤلفون: Ahn, Myung J., Kim, Hye R., Yang, James C. H., Han, Ji-Yu, Li, Jacky Yu-Chung, Hochmair, Maximilian J., Chang, Gee-Chen, Delmonte, Angelo, Lee, Ki H., Campelo, Rosario G., Gridelli, Cesare, Spira, Alexander, I, Califano, Raffaele, Griesinger, Frank, Ghosh, Sharmistha, Felip, Enriqueta, Kim, Dong-Wan, Liu, Yuyin, Zhang, Pingkuan, Popat, Sanjay, Camidge, D. Ross
المساهمون: Kim, Dong-Wan
مصطلحات موضوعية: EML4-ALK FUSION GENE, OPEN-LABEL, CHEMOTHERAPY, ALECTINIB, EGFR, ALK TKI-naive, Anaplastic lymphoma kinase, Clinical trial, First line, Tyrosine kinase inhibitor
العلاقة: Clinical Lung Cancer, Vol.23 No.8, pp.720-730; https://hdl.handle.net/10371/189405Test; 000905581000019; 2-s2.0-85136735466; 177273
-
2دورية أكاديمية
المؤلفون: Cho, Byoung C, Lu, Shun, Felip, Enriqueta, Spira, Alexander I, Girard, Nicolas, Lee, Jong-Seok, Lee, Se-Hoon, Ostapenko, Yurii, Danchaivijitr, Pongwut, Liu, Baogang, Alip, Adlinda, Korbenfeld, Ernesto, Mourão Dias, Josiane, Besse, Benjamin, Lee, Ki-Hyeong, Xiong, Hailin, How, Soon-Hin, Cheng, Ying, Chang, Gee-Chen, Yoshioka, Hiroshige, Yang, James C-H, Thomas, Michael, Nguyen, Danny, Ou, Sai-Hong I, Mukhedkar, Sanjay, Prabhash, Kumar, D'Arcangelo, Manolo, Alatorre-Alexander, Jorge, Vázquez Limón, Juan C, Alves, Sara, Stroyakovskiy, Daniil, Peregudova, Marina, Şendur, Mehmet A N, Yazici, Ozan, Califano, Raffaele, Gutiérrez Calderón, Vanesa, de Marinis, Filippo, Passaro, Antonio, Kim, Sang-We, Gadgeel, Shirish M, Xie, John, Sun, Tao, Martinez, Melissa, Ennis, Mariah, Fennema, Elizabeth, Daksh, Mahesh, Millington, Dawn, Leconte, Isabelle, Iwasawa, Ryota, Lorenzini, Patricia, Baig, Mahadi, Shah, Sujay, Bauml, Joshua M, Shreeve, S Martin, Sethi, Seema, Knoblauch, Roland E, Hayashi, Hidetoshi
المصدر: N Engl J Med ; ISSN:1533-4406
-
3دورية أكاديمية
المؤلفون: Tan, Daniel S. W., Kim, Sang-We, Ponce Aix, Santiago, Sequist, Lecia V., Smit, Egbert F., Yang, James C. H., Hida, Toyoaki, Toyozawa, Ryo, Felip, Enriqueta, Wolf, Juergen, Grohé, Christian, Leighl, Natasha B., Riely, Gregory, Cui, Xiaoming, Zou, Mike, Ghebremariam, Samson, O'Sullivan-Djentuh, Leslie, Belli, Riccardo, Giovannini, Monica, Kim, Dong-Wan
المصدر: Tan , D S W , Kim , S-W , Ponce Aix , S , Sequist , L V , Smit , E F , Yang , J C H , Hida , T , Toyozawa , R , Felip , E , Wolf , J , Grohé , C , Leighl , N B , Riely , G , Cui , X , Zou , M , Ghebremariam , S , O'Sullivan-Djentuh , L , Belli , R , Giovannini , M & Kim , D-W 2022 , ' Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer : ....
الإتاحة: https://doi.org/10.1016/j.ejca.2022.05.023Test
https://research.vumc.nl/en/publications/705c13c3-4ac5-4ff1-b4b4-e996d1dcf18cTest
http://www.scopus.com/inward/record.url?scp=85133930125&partnerID=8YFLogxKTest -
4دورية أكاديمية
المؤلفون: Santoro, Armando, Su, Wu-Chou, Navarro Mendivil, Alejandro, Yang, James C. H., Ardizzoni, Andrea, Felip Font, Enriqueta, Simonelli, Matteo
المساهمون: Institut Català de la Salut, Santoro A, Simonelli M Department of Biomedical Sciences, Humanitas University, Milan, Italy. IRCCS Humanitas Research Hospital–Humanitas Cancer Center, Milan, Italy. Su WC Department of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan. Navarro A, Felip E Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Yang JCH National Taiwan University Cancer Center, Taipei, Taiwan. Ardizzoni A IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Pulmons - Càncer - Tractament, Proteïnes quinases - Inhibidors, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors, Other subheadings::Other subheadings::Other subheadings::/adverse effects, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas, Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos
وصف الملف: application/pdf
العلاقة: Lung Cancer;166; https://doi.org/10.1016/j.lungcan.2022.02.010Test; Santoro A, Su WC, Navarro A, Simonelli M, Yang JCH, Ardizzoni A, et al. Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer. Lung Cancer. 2022 Apr;166:170–7.; https://hdl.handle.net/11351/7972Test; 000789861800003
-
5دورية أكاديمية
المؤلفون: Ahn, Myung-Ju, Kim, Hye R., Yang, James C. H., Han, Ji-Yu, Li, Jacky Y.C., Hochmair, Maximilian J., Felip Font, Enriqueta
المساهمون: Institut Català de la Salut, Ahn MJ Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Kim HR Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. Yang JCH Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Han JY Center for Lung Cancer, National Cancer Center, Goyang, South Korea. Li JY Department of Clinical Oncology, Hong Kong United Oncology Centre, Kowloon, Hong Kong. Hochmair MJ Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria. Felip E Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Pulmons - Càncer - Tractament, Medicaments antineoplàstics - Ús terapèutic, Asiàtics, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos
وصف الملف: application/pdf
العلاقة: Clinical Lung Cancer;23(8); https://doi.org/10.1016/j.cllc.2022.07.008Test; Ahn MJ, Kim HR, Yang JCH, Han JY, Li JY, Hochmair MJ, et al. Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study. Clin Lung Cancer. 2022 Dec;23(8):720–30.; https://hdl.handle.net/11351/8669Test
-
6دورية أكاديمية
المؤلفون: Yang, James C. H., Brose, Marcia S., Castro, Gilberto, Kim, Edward S., Lassen, Ulrik N., Leyvraz, Serge, Pappo, Alberto, López-Ríos, Fernando, Reeves, John A., Fellous, Marc, Penault-Llorca, Frédérique, Rudzinski, Erin R., Tabatabai, Ghazaleh, Vassal, Gilles, Drilon, Alexander, Trent, Jonathan
المساهمون: Bayer
المصدر: BMC Cancer ; volume 22, issue 1 ; ISSN 1471-2407
مصطلحات موضوعية: Cancer Research, Genetics, Oncology
-
7دورية أكاديمية
المساهمون: Boehringer Ingelheim
المصدر: Future Oncology ; volume 17, issue 18, page 2395-2408 ; ISSN 1479-6694 1744-8301
-
8دورية أكاديمية
المؤلفون: Vansteenkiste, Johan, Spigel, David, Yang, James C. H., Ishii, Hidenobu, Garassino, Marina, Ozguroglu, Mustafa, Park, Keunchil
مصطلحات موضوعية: PD-L1, Open-Label, Nivolumab, Multicenter, Avelumab, Non-small cell lung cancer, Second-line, Phase 3
العلاقة: Journal Of Thoracic Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1016/j.jtho.2021.03.009Test; https://hdl.handle.net/11454/76702Test; Uslu, Ruchan/0000-0002-9584-6134; Park, Keunchil/0000-0002-4846-7449; 16; 1369; 1378
-
9دورية أكاديمية
المؤلفون: Park, Keunchil, Ozguroglu, Mustafa, Vansteenkiste, Johan, Spigel, David, Yang, James C. H., Ishii, Hidenobu, Garassino, Marina
مصطلحات موضوعية: Avelumab, PD-L1, Non-small cell lung cancer, Second-line, Phase 3, Open-Label, Nivolumab, Multicenter
العلاقة: Journal Of Thoracic Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1016/j.jtho.2021.03.009Test; https://hdl.handle.net/11454/76702Test; 16; 1369; 1378; WOS:000677967100019; 2-s2.0-85105584972
-
10دورية أكاديمية
المؤلفون: Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C. H., Han, Ji-Youn, Hochmair, Maximilian J., Lee, Ki Hyeong, Delmonte, Angelo, Campelo, D. h Maria Rosario Garcia, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander I., Gettinger, Scott N., Tiseo, Marcello, Lin, Huamao M., Liu, Yuyin, Vranceanu, Florin, Niu, Huifeng, Zhang, Pingkuan, Popat, Sanjay
المساهمون: 김동완, Kim, Dong-Wan
مصطلحات موضوعية: Anaplastic lymphoma kinase, ALK tyrosine kinase inhibitor, Brigatinib, Crizotinib, Non-small cell lung cancer
العلاقة: Journal of Thoracic Oncology, Vol.16 No.12, pp.2091-2108; 149211; https://hdl.handle.net/10371/179088Test; 2-s2.0-85116813235; https://www.sciencedirect.com/science/article/pii/S1556086421023984?via%3DihubTest; 000721176100017
الإتاحة: https://doi.org/10.1016/j.jtho.2021.07.035Test
https://hdl.handle.net/10371/179088Test
https://www.sciencedirect.com/science/article/pii/S1556086421023984?via%3DihubTest
النص الكامل